BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 20839585)

  • 21. Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome.
    ter Horst R; Collin SM; Ritmeijer K; Bogale A; Davidson RN
    Clin Infect Dis; 2008 Jun; 46(11):1702-9. PubMed ID: 18419422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. API consensus guidelines for use of antiretroviral therapy in adults (API-ART guidelines). Endorsed by the AIDS Society of India.
    Gupta SB; Pujari SN; Joshi SR; Patel AK;
    J Assoc Physicians India; 2006 Jan; 54():57-74. PubMed ID: 16649742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Second-line antiretroviral therapy in resource-limited settings: the experience of Médecins Sans Frontières.
    Pujades-Rodríguez M; O'Brien D; Humblet P; Calmy A
    AIDS; 2008 Jul; 22(11):1305-12. PubMed ID: 18580610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of malnutrition on survival and the CD4 count response in HIV-infected patients starting antiretroviral therapy.
    Paton NI; Sangeetha S; Earnest A; Bellamy R
    HIV Med; 2006 Jul; 7(5):323-30. PubMed ID: 16945078
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of virological outcome and safety in primary HIV type 1-infected patients initiating quadruple antiretroviral therapy: QUEST GW PROB3005.
    Hoen B; Cooper DA; Lampe FC; Perrin L; Clumeck N; Phillips AN; Goh LE; Lindback S; Sereni D; Gazzard B; Montaner J; Stellbrink HJ; Lazzarin A; Ponscarme D; Staszewski S; Mathiesen L; Smith D; Finlayson R; Weber R; Wegmann L; Janossy G; Kinloch-de Loes S;
    Clin Infect Dis; 2007 Aug; 45(3):381-90. PubMed ID: 17599319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study.
    Etard JF; Ndiaye I; Thierry-Mieg M; Guèye NF; Guèye PM; Lanièce I; Dieng AB; Diouf A; Laurent C; Mboup S; Sow PS; Delaporte E
    AIDS; 2006 May; 20(8):1181-9. PubMed ID: 16691070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mortality and morbidity among HIV type-1-infected patients during the first 5 years of a multicountry HIV workplace programme in Africa.
    Van der Borght SF; Clevenbergh P; Rijckborst H; Nsalou P; Onyia N; Lange JM; de Wit TF; Van der Loeff MF
    Antivir Ther; 2009; 14(1):63-74. PubMed ID: 19320238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Performance of a World Health Organization first-line regimen (stavudine/lamivudine/nevirapine) in antiretroviral-naïve individuals in a Western setting.
    Tam LW; Hogg RS; Yip B; Montaner JS; Harrigan PR; Brumme CJ
    HIV Med; 2007 Jul; 8(5):267-70. PubMed ID: 17561871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of immune recovery and the association with late mortality while on antiretroviral treatment in Cambodia.
    van Griensven J; Thai S
    Trans R Soc Trop Med Hyg; 2011 Dec; 105(12):694-703. PubMed ID: 21962614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes of the Botswana national HIV/AIDS treatment programme from 2002 to 2010: a longitudinal analysis.
    Farahani M; Vable A; Lebelonyane R; Seipone K; Anderson M; Avalos A; Chadborn T; Tilahun H; Roumis D; Moeti T; Musuka G; Busang L; Gaolathe T; Malefho KC; Marlink R
    Lancet Glob Health; 2014 Jan; 2(1):e44-50. PubMed ID: 25104635
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of treatment outcomes for patients on first-line regimens in US President's Emergency Plan for AIDS Relief (PEPFAR) clinics in Uganda: predictors of virological and immunological response from RV288 analyses.
    Crawford KW; Wakabi S; Magala F; Kibuuka H; Liu M; Hamm TE
    HIV Med; 2015 Feb; 16(2):95-104. PubMed ID: 25124078
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyponatremia, hypochloremia, and hypoalbuminemia predict an increased risk of mortality during the first year of antiretroviral therapy among HIV-infected Zambian and Kenyan women.
    Dao CN; Peters PJ; Kiarie JN; Zulu I; Muiruri P; Ong'ech J; Mutsotso W; Potter D; Njobvu L; Stringer JS; Borkowf CB; Bolu O; Weidle PJ
    AIDS Res Hum Retroviruses; 2011 Nov; 27(11):1149-55. PubMed ID: 21417949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response to antiretroviral therapy: improved survival associated with CD4 above 500 cells/μl.
    Maman D; Pujades-Rodriguez M; Nicholas S; McGuire M; Szumilin E; Ecochard R; Etard JF
    AIDS; 2012 Jul; 26(11):1393-8. PubMed ID: 22441247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mortality of HIV infected clients treated with methadone maintenance treatment in Yili Kazakh autonomous prefecture].
    Liu EW; Wang SJ; Liu Y; Liu W; Chen ZS; Li XY; A LY; Wu ZY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Nov; 45(11):979-84. PubMed ID: 22336271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for mortality in a south Indian population on generic antiretroviral therapy.
    Rupali P; Mannam S; Bella A; John L; Rajkumar S; Clarence P; Pulimood SA; Samuel P; Karthik R; Abraham OC; Mathai D
    J Assoc Physicians India; 2012 Dec; 60():11-4. PubMed ID: 23781664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retention and mortality outcomes from a community-supported public-private HIV treatment programme in Myanmar.
    Mburu G; Paing AZ; Myint NN; Di W; Thu KH; Ram M; Hoffmann CJ; Wang B; Naing S
    J Int AIDS Soc; 2016; 19(1):20926. PubMed ID: 27784509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expansion of HIV-1 screening and anti-retroviral treatment programs in a resource-poor setting: results from a faith-based organization in Jos, Plateau State, Nigeria.
    Lum H; Isichei C; Isichei-Wakili M; Redfield R
    Afr Health Sci; 2007 Jun; 7(2):93-100. PubMed ID: 17594286
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quality of life and social support among patients receiving antiretroviral therapy in Western Uganda.
    Bajunirwe F; Tisch DJ; King CH; Arts EJ; Debanne SM; Sethi AK
    AIDS Care; 2009 Mar; 21(3):271-9. PubMed ID: 19280404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adherence to antiretroviral therapy & its determinants amongst HIV patients in India.
    Sarna A; Pujari S; Sengar AK; Garg R; Gupta I; Dam Jv
    Indian J Med Res; 2008 Jan; 127(1):28-36. PubMed ID: 18316850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of antiretroviral treatment-associated tuberculosis in Ethiopia: a nested case-control study.
    Mesfin N; Deribew A; Yami A; Solomon T; Van Geertruyden JP; Colebunders R
    Int J STD AIDS; 2012 Feb; 23(2):94-8. PubMed ID: 22422682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.